Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Feb 14

PMID 35155621

Authors

Zixiang Ye

Yaxin Wu

Yimin Tu

Mulei Chen

Yanxiang Gao

Linying Shi

Peizhao Li

Enmin Xie

Ziyu Guo

Qing Li

Xiaozhai Yu

Yike Li

Wenquan Niu

Jingyi Ren

Jingang Zheng

Affiliations

Soon will be listed here.

Abstract

Objective: Our study aims to investigate the role of the ABO blood group in the development and severity of coronary artery disease (CAD) in end-stage renal disease (ESRD) patients with dialysis.

Methods: A total of 408 ESRD patients with dialysis between January 2010 and December 2020 were enrolled including 204 patients diagnosed with CAD undergoing coronary angiography for the first time, and baseline characteristics as well as Gensini score (GS) were collected. Logistic regression analysis and linear regression analysis were performed to evaluate the relation of ABO blood types to the risk and severity of CAD, respectively.

Results: Blood group O frequency was significantly low in dialysis ESRD patients with CAD (25 vs. 38.24%) compared with the non-CAD patients and multivariable logistic regression showed blood group O was negatively associated with the risk of CAD [adjusted odds ratio () = 0.33, 95% = 0.19-0.60, < 0.001] as well as the GS tertiles (adjusted = 0.23, 95% = 0.11-0.49, < 0.001) compared with A blood group. Blood group A, B, and AB were positively associated with the high Gensini tertile compared with O blood group (adjusted = 4.26, 95% = 2.03-8.93, < 0.001; adjusted = 2.39, 95% = 1.11-5.13, < 0.05; adjusted = 4.33, 95% = 1.40-13.35, < 0.05). Similarly, multivariable linear regression results revealed O blood type was negatively associated with the GS (β = -26.129, 95% = -40.094 to -12.164, < 0.001).

Conclusion: This case-control study demonstrated that blood group O was a potential independent protective factor for the risk and severity of CAD in ESRD patients with dialysis.

Citing Articles

Time to death and its predictors among patients with chronic kidney disease on hemodialysis at dialysis unit in Addis Ababa, Ethiopia: a retrospective cohort study.

Tesfaye A, Birhanu A, Kolola T, Hamza L, Etana D BMC Nephrol. 2024; 25(1):279.

PMID: 39198767 PMC: 11360759. DOI: 10.1186/s12882-024-03719-3.

References

Teng M, Hsu L, Wu S, Chou H, Chang C, Sun Y . Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level. Atherosclerosis. 2013; 228(2):406-12. DOI: 10.1016/j.atherosclerosis.2013.03.032. View

Rosenberg L, Miller D, Kaufman D, Helmrich S, Van de Carr S, STOLLEY P . Myocardial infarction in women under 50 years of age. JAMA. 1983; 250(20):2801-6. View

Zhang H, Mooney C, Reilly M . ABO Blood Groups and Cardiovascular Diseases. Int J Vasc Med. 2012; 2012:641917. PMC: 3485501. DOI: 10.1155/2012/641917. View

Di Lullo L, House A, Gorini A, Santoboni A, Russo D, Ronco C . Chronic kidney disease and cardiovascular complications. Heart Fail Rev. 2014; 20(3):259-72. DOI: 10.1007/s10741-014-9460-9. View

Chion C, Doggen C, Crawley J, Lane D, Rosendaal F . ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood. 2006; 109(5):1998-2000. DOI: 10.1182/blood-2006-07-038166. View

Rampidis G, Benetos G, Benz D, Giannopoulos A, Buechel R . A guide for Gensini Score calculation. Atherosclerosis. 2019; 287:181-183. DOI: 10.1016/j.atherosclerosis.2019.05.012. View

Sinning C, Lillpopp L, Appelbaum S, Ojeda F, Zeller T, Schnabel R . Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol. 2013; 102(7):495-503. DOI: 10.1007/s00392-013-0555-4. View

Fu E, Andersson Franko M, Obergfell A, Dekker F, Gabrielsen A, Jernberg T . High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients. Am Heart J. 2019; 216:20-29. DOI: 10.1016/j.ahj.2019.06.019. View

Crawley J, de Groot R, Xiang Y, Luken B, Lane D . Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 2011; 118(12):3212-21. PMC: 3179391. DOI: 10.1182/blood-2011-02-306597. View

10.

Matsui T, Titani K, Mizuochi T . Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem. 1992; 267(13):8723-31. View

11.

Zhao D, Liu J, Wang M, Zhang X, Zhou M . Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2018; 16(4):203-212. DOI: 10.1038/s41569-018-0119-4. View

12.

Sokunbi D, Wadhwa N, Suh H . Vascular disease outcome and thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis. Adv Perit Dial. 1994; 10:77-80. View

13.

Hong X, Li Y, Fu G, Wu H, Wang Y, Gu C . Association of ABO blood groups with the severity of coronary artery disease: a cross-sectional study. J Geriatr Cardiol. 2019; 16(9):701-705. PMC: 6790955. DOI: 10.11909/j.issn.1671-5411.2019.09.005. View

14.

Tekin I, Pocan B, Borazan A, Ucar E, Kuvandik G, Ilikhan S . Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients. Ren Fail. 2008; 30(2):219-25. DOI: 10.1080/08860220701813350. View

15.

Kanda H, Hirasaki Y, Iida T, Kanao-Kanda M, Toyama Y, Chiba T . Perioperative Management of Patients With End-Stage Renal Disease. J Cardiothorac Vasc Anesth. 2017; 31(6):2251-2267. DOI: 10.1053/j.jvca.2017.04.019. View

16.

Saran R, Robinson B, Abbott K, Agodoa L, Albertus P, Ayanian J . US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017; 69(3 Suppl 1):A7-A8. PMC: 6605045. DOI: 10.1053/j.ajkd.2016.12.004. View

17.

Karabuva S, Carevic V, Radic M, Fabijanic D . The association of ABO blood groups with extent of coronary atherosclerosis in Croatian patients suffering from chronic coronary artery disease. Biochem Med (Zagreb). 2013; 23(3):351-9. PMC: 3900083. DOI: 10.11613/bm.2013.043. View

18.

Levin A, Thompson C, Ethier J, Carlisle E, Tobe S, Mendelssohn D . Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999; 34(1):125-34. DOI: 10.1016/s0272-6386(99)70118-6. View

19.

Ma Q, Jacobi P, Emmer B, Kretz C, Ozel A, McGee B . Genetic variants in as well as smoking are major determinants of plasma ADAMTS13 levels. Blood Adv. 2018; 1(15):1037-1046. PMC: 5728318. DOI: 10.1182/bloodadvances.2017005629. View

20.

Reynolds H, Shaw L, Min J, Page C, Berman D, Chaitman B . Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity. Circulation. 2021; 144(13):1024-1038. PMC: 8478888. DOI: 10.1161/CIRCULATIONAHA.120.049755. View